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Myelodysplasia syndrome 1 (MDS1) and Ecotropic viral integration site 1 
(EVI1) complex (MECOM) locus encode multiple isoforms of the EVI1 pro-
tein that are essential for normal vertebrate development and when inappro-
priately expressed play a significant role in malignancy and in particular leu-
kaemias. However, the function of individual EVI1 isoforms is not fully un-
derstood. Recently, EVI1 or PRDM3, which is structurally closely related to 
the brown adipose tissue determining factor PRDM16, was shown to be required 
for differentiation of adipocytes. In this study, we show that 3T3-L1 preadipo-
cytes sustain expression of all Evi1 isoforms examined, including Mds1-Evi1, 
Evi1FL, Evi1Δ324, Evi1FL + 9 and Evi1Δ105 throughout the adipogenesis dif-
ferentiation programme. We also show that differentiation markers are en-
hanced by enforced expression of either Evi1, Evi1FL + 9 or Evi1Δ105 iso-
forms. Interestingly 3T3-L1 differentiation markers are also moderately en-
hanced by enforced expression of Evi1Δ324, which lacks part of the N-ter- 
minal zinc finger domain (ZF1), demonstrating a biological activity for this 
particular isoform. Enforced expression of an Evi1 mutant lacking C-terminal 
binding protein (CtBP) co-repressor protein binding activity fails to stimulate 
3T3-L1 differentiation markers and may have dominant negative activity, caus-
ing partial inhibition of this developmental programme. These studies show 
that multiple EVI1 isoforms are expressed in adipocytes and can stimulate adi-
pogenic markers in a manner that is partially independent of the ZF1 DNA 
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1. Introduction 
Myelodysplasia syndrome 1 (MDS1) and Ecotropic virus integration site 1 (EVI1) 
complex (MECOM) locus gene transcripts include MDS1, EVI1 and a fusion of 
part of MDS1 with EVI1 [1] and their inappropriate expressions are associated 
with poor prognosis leukaemias and other malignancies [2] [3]. Those tran-
scripts containing EVI1 encode transcription factors with multiple cys2his2 zinc 
finger DNA binding motifs [4] and are required for mammalian development 
[5]. EVI1 has been shown to contribute to a number of developmental programmes 
including maintenance of haemopoietic stem cells and various committed pro-
genitor cells in haemopoiesis [6], neuroectodermal cell differentiation [7], neph-
rogenesis [8] and cardiac development [9]. 
EVI1 is also known as positive regulatory domain I-binding factor 1, retinob-
lastoma protein-binding zinc finger protein (PR) domain protein 3 (PRDM3) 
and the structurally similar PRDM16 is a key regulator of brown adipose tissue 
development [10]. Recent studies show that EVI1 also participates in adipogene-
sis [11] [12]. These studies show that EVI1 converts nonadipogenic cells to adi-
pocytes and knockdown (KD) suppresses preadipocyte differentiation by im-
pairing CCAAT/Enhancer-binding protein-beta (CEBPβ) assisted induction of 
peroxisome proliferator-activated receptor-gamma 2 (PPARγ2).  
There are multiple naturally occurring isoforms of EVI1 but it is not known 
which are expressed in preadipocytes and which might participate in adipogene-
sis as all are potentially affected in the knockdown (KD) study of Ishibashi et al., 
2012. The isoforms include MDS1-EVI1, EVI1FL, EVI1Δ324 [13], EVI1RP+ and 
EVI1Δ105 (murine specific) [14]. MDS1-EVI1 comprises intergenic transcripts 
containing coding exons of both the MDS1 and the EVI1 genes and encodes an 
EVI1 protein with an N-terminal PR domain. EVI1FL is the original full length 
murine protein encoded by the cDNA first isolated from leukaemia cells [4]. 
EVI1RP+ is similar to EVI1FL but has an additional 9 amino acids inserted 
within the repressor domain (RP). EVI1Δ324 lacks 324 amino acids, including 
part of the first zinc finger domain up to, but excluding, RP and EVI1Δ105 has 
105 C-terminal amino acids deleted. Various properties have been attributed to 
some of these isoforms and in some instances they have been shown to have 
opposing activities. For example, MDS1-EVI1 has been associated with tumor 
suppressing activity whereas EVI1FL is oncogenic. MDS1-EVI1 activates AGATA 
motif promoters whereas EVI1FL represses [1], EVI1FL inhibits 32Dcl3 cell re-
sponse to granulocyte-colony stimulating factor (G-CSF) and transforming growth 
factor beta (TGFβ1) whereas MDS1-EVI1 has no effect on G-CSF response and 
enhances TGFβ1 signalling [15] and EVI1FL enhances proliferation of haemo-
poietic colonies from differentiating embryonal stem (ES) cells whereas MDS1-EVI1 
represses these activities [16]. The MDS1-EVI1 isoform has a PR domain [17] 
which confers intrinsic histone H3 lysine 9 monomethyltransferase catalytic ac-
tivity [18] which is absent from other EVI1 isoforms.  
The significance of the remaining isoforms remains unclear. Studies show ex-
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pression of each isoform in all tissues examined but little difference in DNA 
binding, CtBP protein binding, transcriptional repression or cell transformation 
activities between EVI1FL, EVI1RP+ or EVI1Δ105 [14]. EVI1Δ324 however lacks 
3 N-terminal zinc fingers (ZF1), neither binds nor represses transcription via 
ZF1 DNA binding sites, does not transform fibroblasts [19] and to date no bio-
logical activity has been assigned to this isoform.  
In this study we investigate the profile of expression and biological activity of 
EVI1 isoforms in 3T3-L1 preadipocytes and throughout the adipocyte differen-
tiation programme.  
2. Materials and Methods 
2.1. Cell Culture 
Plat-E (Cambridge Bioscience, Cambridge, UK, RV-101) and 3T3-L1 (ATCC 
CL-173) cells were cultured in complete medium (CM) comprising Dulbecco’s 
Modified Eagle’s Medium (Lonza Group Ltd., Basel, Switzerland, BE12-604F) sup-
plemented with 10% (v/v) newborn calf serum (3T3-L1) (Sigma-Aldrich, Poole, 
UK, N4637) or 10% (v/v) foetal calf serum (Plat-E cells) (FCS, Lonza, DE14-801F) 
and 2.5 mM glutamine, 50 μg/ml penicillin, 50 units/ml streptomycin (Lonza 
Group Ltd., BE17-605E and BE17-603E), 37˚C, 5% CO2. For differentiation 3T3-L1 
were cultured with induction medium 1 (IM1), comprising CM with 10% (v/v) FCS, 
5 μg/ml insulin (Sigma-Aldrich, I9278), 0.25 μM dexamethasone (Sigma-Aldrich, 
D4902), 0.5 mM Isobutylmethylxanthine (IBMX, Sigma-Aldrich I5879), for 48 h fol-
lowed by a further 48 h incubation with induction medium 2 (IM2) comprising CM 
supplemented with 10% FCS and 5 μg/ml insulin. Culture medium was subse-
quently replaced with fresh IM2 every 48 h for up to 10 days. For retrovirus pro-
duction, Plat-E cells were transiently transfected with retroviral plasmid DNA using 
Fugene6® (Roche Diagnostics GmbH, Mannheim, Germany, 11815091001); virus 
was harvested and used to infect 3T3-L1 as described before [20].  
2.2. Preparation of Total Cellular RNA, cDNA Synthesis and  
Quantitative Real-Time Polymerase Chain Reaction QPCR 
RNA was prepared from cultures of cells by the TRI Reagent method (Sigma-Aldrich, 
93289). Total cellular RNA (1 μg) was used to synthesise cDNA using Maxima re-
verse transcriptase (Thermo Fisher Scientific Inc., St. Leon-Rot, Germany, EP0742) 
with random hexamer (Thermo Fisher Scientific, S0142) and oligo dT (Thermo 
Fisher Scientific, S0131) primers according to the manufacturer’s instructions. The 
cDNA reaction (5%) was used for real time quantitative polymerase chain reaction 
using QPCR SYBR Green mix (Thermo Fisher Scientific, 11873913), gene specific 
oligonucleotide primers (Integrated DNA Technologies, Leuven, Belgium), 95˚C, 
15 min followed by 40 cycles 95˚C, 30 s, 60˚C, 30 s in a CFX96 C1000 Thermal cyc-
ler (BIO-RAD Laboratories Ltd., Hemel Hempstead, UK). 
The efficiency of the Q-PCR reactions were calculated by using the formula 
Efficiency = −1 + 10(−1/slope) against the standard curve of each assay over a gra-
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dient of template concentration with each gene. The efficiency of primers are 
Ca3 (88%), C/ebpα (75%), Pparγ2 (92%), Fabp4 (91%), Evi1 (101%) and Gapdh 
(90%). Relative expression levels between target and Gapdh were determined 
using the arithmetic comparative 2−∆∆Ct method [21] and were determined rela-
tive to the target gene in MX infected 3T3-L1 cells (calibrator). Oligonucleotide 
primers were supplied by Integrated DNA Technologies (Leuven, Belgium) 
Pparγ2FP: GCCCACCAACTTCGGAATC, Pparγ2RP: TGCGAGTGGTCTTCC 
ATCAC, C/ebpαFP: GAGCTGAGTGAGGCTCTCATTCT, C/ebpαRP: TGGGA 
GGCAGACGAAAAAAC, Fabp4FP: GGGCGTGGAATTCGATGAAATCA, Fab 
p4RP: CCCGCCATCTAGGGTTATGAT, Evi1FP: CGCTTGAAGCTTTGAAAG 
AAAAATA, Evi1RP: TGTTCTCAATTGCTGACATTTGC, Evi1 probe (HEX): 
TTGAGACCTTCTCCAGGATTCTTGTTTCACC, Ca3FP: CCGGGACTATTGG 
ACCTATCAC, Ca3RP: TTGAGCAGCAGCCACACAA, Ca3 probe (FAM): CTCC 
TTCACCACGCCGCCCTG, GapdhFP: GGGCTGCCCAGAACATCA, GapdhRP: 
CCGTTCAGCTCTGGGATGAC, Gapdh probe (FAM): CCCTGCATCCACTG 
GTGCTGCC. 
2.3. Endpoint PCR 
cDNA (0.5 μl) was amplified by PCR with 140 ng/μl forward and reverse primers 
using ReddyMix PCR master mix [1.5 mM MgCl2] (Thermoscientific) 95˚C, 5 
min followed by 40 cycles 95˚C, 15 s, 60˚C, 60 s in a PTC-100™ Thermal cycler 
(MJ Research, Inc.). Products were analysed by 3% (w/v) agarose gel electrophore-
sis in 40 mM Tris-acetate, 1 mM EDTA (pH 8.0) buffer (1XTAE). Oligonucleo-
tide primers were supplied by Integrated DNA Technologies. Mds1/Evi1 and 
Evi1 specific primers were EF, MF1 and GSP3 [22], RP+ primers were ME1/ME3 
and Δ105 primers were ME2/ME4 [14] and Δ324 primers were Δ324F: CGTCA 
GGGCCTCAAACAGC, Δ324R: GGGTACATTGATTGAGAGAATGAGA. CtBP 
1 and 2 primers were: CtBP1FP; CACACAGGAGATCCATGAGAAG, CtBP1RP; 
CTCTGGTCAGTGTGATGGTATG, CtBP2FP; GCACAGTCCACTCAGGAAAT, 
CtBP2RP; CCTTGAACTTCTCCAGGTCTTC. 
2.4. Western Blot Analysis 
Protein extracts, SDS polyacrylamide gel electrophoresis and western blotting 
were performed as described previously [23] with either α-EVI1 (1806) or α-GAPDH 
(Fitzgerald Industries, North Acton, MA, USA, 6C5) diluted 1/1000 (1806) or 
1/5000 (6C5) respectively. Appropriate IRDye 800CW conjugated anti-rabbit 
(Li-Cor Biosciences, 926-32211) or IRDye 680RD conjugated anti-mouse (Li-Cor 
Biosciences, 926-68072) IgG secondary antibodies were used at 1/15000 dilu-
tions and detection was performed by fluorescence using an Odyssey Fc Imaging 
System (Li-Cor Biosciences). 
2.5. Statistical Analysis 
Unpaired Student’s t-test was used to determine the significance of data using 
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Graphpad Prism® 6.0 software. P ≤ 0.05 was considered significant. *P ≤ 0.05, 
**P ≤ 0.01, ***P ≤ 0.001, ns not significant. 
3. Results 
3.1. Enforced Expression of EVI1 in 3T3-L1 Preadipocytes 
In order to investigate the effect of EVI1 expression on adipogenesis it was ex-
pressed in 3T3-L1 cells. Initially Plat-E cells were transiently transfected with the 
previously described Evi1FL encoding p50M5.6-neo retroviral vector [20] and the 
resulting virus containing supernatants used to infect varying numbers of 3T3-L1 
cells (Materials and Methods). The 3T3-L1 cells were re-infected with virus con-
taining supernatant again 24 hrs later. After virus infection (48 h) cells were 
examined for Evi1 expression by western blot analysis with α-EVI1. The results 
show production of the 145 kd Evi1 protein in cells infected with the 5.6 retro-
viral vector (Figure 1(a)). Even loading of samples was confirmed by western 
blot analysis with α-GAPDH (Figure 1(a)). Highest Evi1 expression is observed 
when either 2 × 104 or 5 × 104 cells were used for virus infection and therefore 5 
× 104 cells were chosen for further experiments.  
3.2. EVI1 Enhances 3T3-L1 Adipocyte Differentiation 
To investigate the impact of enforced EVI1FL expression on adipogenesis it was 
expressed in 3T3-L1 cells using the transient retroviral infection scheme and 
subsequent induction of adipocyte differentiation programme outlined in Figure 
1(b). Cells were transiently infected with either p50MX-neo (MX, empty vector 
control) or p50M5.6-neo (5.6) virus, induced to differentiate and RNA prepared 
from cell extracts at various time points. Initially, expression of the adipocyte 
differentiation marker gene Fabp4 at days 0 and 10 were examined. The results 
show induction of this marker for both control infected cells as well as cells with 
enforced expression of Evi1 (Figure 1(c), MX, 5.6), however the induction of 
Fabp4 is significantly increased in cells with enforced Evi1 expression at day 10 
compared to MX infected cells on the same day (Figure 1(c), 5.6).  
We next examined expression of key regulators of adipocyte differentiation 
Pparγ2 and C/ebpα in the presence (5.6) or absence (MX) of Evi1 at days 0, 1, 2, 
3 and 4 of induction. The results show that both markers are induced during the 
4 day period but accumulate to significantly higher levels in the presence of Evi1 
(Figure 2(a), Figure 2(b), 5.6) when compared with empty vector infected cells 
at each point examined (Figure 2(a), Figure 2(b), MX). Pparγ2 expression in-
itially declines between day 0 and days 1 and 2 in MX and 5.6 cells but one-way 
ANOVA and Dunnett’s multiple comparison post-test using MX day 0 or 5.6 
day 0 as control group confirms significant increases by day 4 [P ≤ 0.001 (MX), 
P ≤ 0.05 (5.6)]. Other studies have shown that the enzyme carbonic anhydrase 
III (Ca3) is induced during adipocyte differentiation [24] and is either a marker 
or regulator of this process. Ca3 gene expression increases significantly (D1 p ≤ 
0.01, D2, D3 and D4, P ≤ 0.001) in control MX cells compared to levels at D0 in- 
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Figure 1. (a) Western blot analysis of whole cell protein extracts derived from 3T3-L1 
cells transiently infected with p50M5.6neo retrovirus. The number of cells exposed to re-
trovirus is shown at the top of each lane. The size of Evi-1 and Gapdh proteins observed 
with α-Evi1 and α-Gapdh are indicated; (b) Strategy for transient retroviral infection of 
3T3-L1 cells and timeline for induction of differentiation. Complete media (CM1), induc-
tion media 1 (IM1) and 2 (IM2) are described in materials & methods; (c) Histogram 
showing relative gene expression of Fabp4 in empty vector control (MX, clear bars) and 
Evi1 vector (5.6, black bars) infected 3T3-L1 cells at days 0 (D0) and 10 (D10) of differen-
tiation. Error bars are the standard deviation of 3 (n = 3) independent virus infection and 
differentiation experiments. ***P ≤ 0.001 indicates statistical significance of MXD10 vs. 
MXD0 and 5.6D10 vs. MXD10. 
 
 
Figure 2. Histograms showing relative gene expression of C/ebpα (a), Pparγ2 (b), Ca3 (c) 
and Evi1 (d) in empty vector control (MX, white bars) and Evi1 vector (5.6, black bars) 
virus infected 3T3-L1 cells at days 0 (D0), 1 (D1), 2 (D2), 3 (D3) and 4 (D4) of differen-
tiation. Error bars are the standard deviation of 3 (n = 3) independent virus infection and 
differentiation experiments. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 indicates statistically sig-
nificant differences in expression of the indicated gene for EVI1 expressing cells (5.6) 
compared to MX infected cells on the same day. 
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dicating progression through the differentiation programme. Comparison of Ca3 
gene expression in MX and 5.6 cells shows its expression is significantly elevated 
in 3T3-L1 cells with enforced expression of Evi-1 (Figure 2(c), 5.6) compared 
with cells examined at the same time point that were infected with the empty 
vector (Figure 2(c), MX). Finally, Evi1 transgene expression was maintained for 
at least the 4 day duration of the transient expression and differentiation system 
as its mRNA expression is significantly higher in 5.6 infected cells compared 
with low, but detectable, endogenous Evi1 expression observed in MX infected 
3T3-L1 cells at each time point examined (Figure 2(d), MX, 5.6).  
3.3. Naturally Occurring EVI1 Splice Variants, RP+, Δ105 and  
Δ324 Stimulate 3T3-L1 Adipocyte Differentiation 
These data suggest enforced expression of Evi1 accelerates adipocyte differentia-
tion of induced 3T3-L1 cells. Multiple, naturally occurring Evi1 splice variants 
exist in murine cells [14]. A schematic representation of the isoform shown to 
stimulate adipocyte differentiation (Figure 2) is shown in Figure 3, designated 
EVI1FL, along with other splice variants MDS1/EVI1, EVI1RP+ (RP+), EVI1Δ324 
(Δ324) and EVI1Δ105 (Δ105). Endogenous expression of each of these in 3T3-L1 
cells, in preadipocytes (Figure 4(a)) and throughout 10 days of differentiation 
(data not shown), was confirmed using isoform specific oligonucleotide primers 
(Materials and Methods) by end point PCR.  
Since all isoforms examined are expressed in 3T3-L1 cells we investigated 
which can induce adipocyte differentiation. Previously described retroviral vec-
tors [14] [19] were used to transiently express each isoform (RP+, Δ324 and Δ105) 
in 3T3-L1 cells. Infected cells were induced to differentiate and similar levels of 
 
 
Figure 3. Schematic representation of the domain structure of the indicated EVI1 splice 
variant encoded proteins showing the PR domain (PR), 1st and second 2nd zinc finger 
domains (ZF1 & ZF2), repressor domain (Rp), acidic domain (Ac), CtBP binding sites 1 
& 2 and the additional 9 amino acids (single letter amino acid code) found in the repres-
sor domain of Rp+. X indicates CtBP binding inactivating point mutations. 
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Figure 4. (a) Agarose gel (3% NuSieve® 3-1 agarose, Lonza) electrophoresis of end point 
PCR products for EVI1 splice variants at day 0 of 3T3-L1 cell differentiation. White ar-
rows indicate amplified DNA fragments of the expected size for each splice variant: 
MSD1/EVI1 460 bp; EVI1FL 298 bp; EVI1Δ324 76 bp; EVI1RP+/EVI1FL 216 bp/189bp; 
EVI1Δ105/EVI1FL 187 bp/371bp. Marker is 100 bp ladder (quickload, New England Bi-
olabs); (b) Histogram showing relative gene expression of Evi1 in empty vector control 
(MX, white bars) and indicated Evi1 splice variant vector infected 3T3-L1 cells at days 0 
(D0) and 4 (D4) of differentiation. Error bars are the standard deviation of 3 (n = 3) in-
dependent virus infection and differentiation experiments. There is no statistically signif-
icant difference in expression of each mutant form relative to EVI1RP+ (RP+) at day 0. 
 
ectopic expression of Evi1 splice variants was achieved over the 4 days examined 
(Figure 4(b)). 
Cells were then examined for expression of Fabp4, Ca3 (day 0 and 10), Pparγ2 
and C/ebpα (day 0, 1, 2, 3 and 4). In each case gene expression in Evi1 isoform 
expressing cells was compared to MX infected cells on the same day. Surprising-
ly, the results show a significant increase in induction of Fabp4 (Figure 5(a)) 
and Ca3 (Figure 5(b)) expression in induced 3T3-L1 cells at day 10 with each 
isoform examined. Furthermore, both RP+ or Δ105 isoform expression results in 
a significant increase in C/ebpα and Pparγ2 (Figure 6(a), Figure 6(b), RP+ D3 
and 4, Δ105 D3 and 4 vs. MXD3 and 4) gene expression. Δ324 transgene expres-
sion results in a significant increase in both C/ebpα and Pparγ2 gene expression 
at day 3 (Figure 6(a), Figure 6(b), Δ324D3 vs. MXD3) but no significant change 
at day 4 (Figure 6(a), Figure 6(b), Δ324D4 vs. MXD4). 
3.4. Interaction with CtBP Proteins Is Required for EVI1 Mediated  
Stimulation of 3T3-L1 Adipogenesis 
The results suggest that enforced expression of each naturally occurring Evi1 
isoform tested can stimulate adipogenesis in induced 3T3-L1 cells. Evi1 interacts 
with CtBP proteins to mediate some biological activities and so we investigated if 
this interaction is required to stimulate adipocyte differentiation markers as well. 
A retroviral vector encoding a CtBP binding mutant EVI1ΔCtBP1/2 (ΔCtBP1/2)  
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Figure 5. Histograms showing relative gene expression of Fabp4 (a) and Ca3 (b) in empty 
vector control (MX) and EVI1RP+ (RP+), EVI1Δ105 (Δ105), EVI1Δ324 (Δ324) and 
EVI1ΔCtBP1/2 (ΔCtBP1/2) virus infected 3T3-L1 cells at days 0 (D0) and 10 (D10) of 
differentiation. Error bars are the standard deviation of 3 (n = 3) independent virus infec-
tion and differentiation experiments. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 indicates statisti-
cally significant differences in expression of the indicated gene for each form of EVI1 rel-
ative to MX infected cells at day 10. 
 
(Figure 3) that is unable to bind CtBP proteins [25] was transiently expressed in 
3T3-L1 cells. The cells were induced to differentiate and examined for expression 
of the same molecular markers as before. ΔCtBP1/2 mutant transgene expres-
sion was observed at similar levels to the other Evi1 isoforms studied (Figure 
4(b), ΔCtBP1/2 D0 and D4). The results show that instead of an increase, there 
is a significant decrease in Fabp4 (Figure 5(a), Figure 5(b), ΔCtBP1/2 D10), 
C/ebpα and Pparγ2 (Figure 6(a), Figure 6(b), ΔCtBP1/2 D4) gene expression in 
ΔCtBP1/2 expressing cells when compared to cells infected with the empty vec-
tor (MX) control on the same days. Only Ca3 gene expression shows a small in-
crease in expression in cells with enforced ΔCtBP1/2 expression (Figure 5(b), 
ΔCtBP1/2 D10). Expression of both CtBP1 and CtBP2 genes are observed 
throughout the 3T3-L1 cell differentiation programme (Figure 6(c)). These data 
show that Evi1 mediated stimulation of 3T3-L1 cell differentiation markers is 
dependent on interaction with CtBP binding proteins. 
4. Discussion 
In this study a transient retroviral infection system was developed to investigate 
the effect of enforced EVI1 expression on 3T3-L1 pre-adipocyte cell differentia-
tion to adipocytes. Results show that under these conditions EVI1 enhances chemi-
cally induced 3T3-L1 differentiation as measured by characteristic gene markers 
and mediators of this process (Fabp4, Ca3, C/ebpα and Pparγ2). Furthermore, 
we show that all previously described and naturally occurring EVI1 splice va-
riants are expressed in 3T3-L1 preadipocytes as well as throughout the differen-
tiation programme and that enforced expression of splice variants EVI1RP+, 
EVI1Δ105 and EVI1Δ324 similarly enhance the process. Finally, we demonstrate 
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Figure 6. Histograms showing relative gene expression of C/ebpα (a) and Pparγ2 (b), in 
empty vector control (MX) and EVI1Rp+9 (Rp+), EVI1Δ105 (Δ105), EVI1Δ324 (Δ324) 
and EVI1ΔCtBP1/2 (ΔCtBP1/2) virus infected 3T3-L1 cells at days 0 (D0), 1 (D1), 2 (D2), 
3 (D3) and 4 (D4) of differentiation. Error bars are the standard deviation of 3 (n = 3) in-
dependent virus infection and differentiation experiments. Statistical analysis of days 3 
(D3) and 4 (D4) data only are shown. **P ≤ 0.01, ***P ≤ 0.001 indicates statistically sig-
nificant differences in expression of the indicated gene for each form of EVI1 relative to 
MX infected cells on the same day. ns indicates no significant difference in expression 
relative to MX infected cells on the same day. (c) Agarose gel (3% NuSieve® 3-1 agarose) 
electrophoresis of end point PCR products for CtBP1 and CtBP2 gene expression at indi-
cated days 0, 1, 2, 3, 4, 6 and 10 of 3T3-L1 cell differentiation. M indicates 100 bp ladder 
marker (quickload) and C the negative control. 
 
that a mutant of EVI1, which no longer binds CtBP proteins, is unable to sti-
mulate the 3T3-L1 differentiation markers that are observed with wild type va-
riants.  
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The efficiency of differentiation of empty vector control 3T3-L1 cells is subop-
timal as indicated by relatively small changes in molecular marker gene expres-
sion shown in Figure 1(c); Figures 2(a)-(c); Figure 5(a) & Figure 5(b) and 
Figure 6(a) & Figure 6(b). In the virus infection and differentiation scheme 
used here (Figure 1(b)) 3T3-L1 cells are unlikely to be confluent for 48 hrs prior 
to induction of differentiation as is normally the case [26] because of the need to 
optimize retroviral infection in dividing cells [27]. However, our results clearly 
show that differentiation is significantly enhanced by enforced expression of EVI1 
under these conditions, based on the molecular markers examined. Following 
growth arrest, efficient induction of 3T3-L1 cell differentiation is accompanied by 
mitotic clonal expansion (MCE) [28]. Studies have shown that EVI1 stimulates 
cell proliferation [29] and this property may stimulate MCE, contributing to the 
enhanced expression of adipogenic markers observed here, which are consistent 
with previous observations [11].  
All known naturally occurring EVI1 splice variants are expressed in preadi-
pocytes and throughout differentiation of 3T3-L1 cells. The relative abundance 
of splice variants has not been determined in this study but others have shown 
that general EVI1 expression is low in proliferating preadipocytes, transiently 
peaks during chemical stimulation of differentiation then is low again for the 
remaining programme [11]. 
Enforced expression of splice variants EVI1FL, EVI1RP+, EVI1Δ105 and 
EVI1Δ324 are each capable of stimulating adipocyte differentiation based on 
relative increases in programme mediator (Cebpα, Pparγ2) and marker (Fabp4, 
Ca3) gene expression (Figure 2, Figure 5, Figure 6). It is interesting that EVI1Δ324 
can stimulate adipogenic markers as this represents one of the few biological ac-
tivities associated with the isoform to date. This splice variant lacks part of zinc 
finger 6 and all of zinc finger 7 of the ZF1 domain as well as 275 intervening 
amino acids to the Rp domain [30]. Recent studies show EVI1FL and EVI1Δ324 
co-regulate largely the same genes in cells and that EVI1Δ324 can induce an-
chorage independent growth in HeLa cells [31]. However, our results show 
EVI1Δ324 cannot fully complement the activity of the other EVI1 splice variants 
studied as stimulation of gene expression of the markers examined is less in 
most cases when compared with the other isoforms. This indicates the missing 
amino acids, including the ZF1 domain, are important for optimal EVI1 me-
diated stimulation of adipogenesis. 
The interaction of EVI1 with CtBP proteins has previously been shown to be 
essential for biological activities including cell transformation [25] and inhibi-
tion of TGFβ signaling [32]. This study shows EVI1 mediated stimulation of adi-
pogenic markers is also CtBP binding dependent. Interestingly, EVI1ΔCtBP1/2 
not only fails to stimulate adipogenic markers in 3T3-L1 cells but it actually ap-
pears to repress them when compared with MX infected cells. Gene expression 
of Fabp4, C/ebpα and Pparγ2 are all significantly repressed in EVI1ΔCtBP1/2 
expressing cells (Figure 5 and Figure 6) which suggests it has dominant negative 
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activity with regard to adipocyte differentiation. Other regulators of adipogene-
sis are also dependent upon CtBP complexes including Klf3 [33], Fog1 and Fog2 
[34]. Both CtBP1 and CtBP2 are expressed throughout adipocyte differentiation 
(Figure 6(c)) and their binding is required for both negative (Klf3, Fog1 and Fog2) 
and positive (EVI1) regulation. Furthermore, the EVI1 related protein PRDM16 
also binds CtBP proteins to repress white fat specific genes and are displaced to 
promote brown adipose tissue development [35]. CtBP proteins bind NAD+ and 
NADH with higher affinity for the latter which promotes interaction with part-
ner proteins [36]. CtBP proteins have been proposed to have a role in metabolic 
sensing [37]. High calorie intake is associated with increased levels of NADH. 
Based on our study this would be predicted to promote association of EVI1 and 
CtBP and stimulate adipogenesis. 
Obesity, the expansion of adipose tissue depots, is one underlying cause of 
major health conditions worldwide including both type 2 diabetes mellitus and 
cardiovascular disease, but the mechanisms involved are not fully understood. 
Understanding the molecular mechanisms regulating adipogenesis might iden-
tify novel targets for therapeutic intervention. Regulation of the adipogenesis 
developmental programme is controlled by a complex network of transcription 
factors and EVI1 has only recently been identified to be involved in this process. 
These studies show for the first time that multiple EVI1 isoforms are expressed 
in adipocytes and can stimulate adipogenic markers in a manner that is partially 
independent of the ZF1 DNA binding domain but fully dependent upon interac-
tion with co-repressor CtBP proteins. Blocking EVI1/CtBP interaction may be a 
target for drug development controlling obesity. 
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